Betaine anhydrous: new drug. Homocystinuria: continued evaluation needed.
D001622:Betaine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D017277:Drug Approval; D005060:Europe; D006712:Homocystinuria / Q000188:drug therapy*; D006801:Humans; D009965:Orphan Drug Production
D001622:Betaine